Study on the Method Validation of Recombinant Factor C Endotoxin Testing Assay
Article Sidebar
Main Article Content
Abstract
Background: Bacterial endotoxins, the pyrogens derived from gram-negative bacteria, are heat-stable and can contaminate vaccine, injectable drug, and medical device products for human and veterinary use during manufacturing. The Limulus Amebocyte Lysate (LAL) method for analyzing the endotoxin determination uses a lysate of horseshoe crab blood, which has a high post-bleeding mortality rate. In accordance with the 3Rs principle of animal welfare, there has been a global effort to find a replacement for the use of animals. A recombinant factor C (rFC) assay has been developed as a replacement for the horseshoe crab lysate assay. Currently, the European and United State Pharmacopoeias have recognized it as a standard method.
Objectives: To study the validation of the recombinant factor C method for analyzing the endotoxin determination for use as a standard method in quality control of biological products to cover all analytical methods in European and United Stated pharmacopoeias.
Methods: This experimental research was conducted from October 2022 to December 2023 for validation of the endotoxin determination using recombinant factor C method in the parameters such as linearity, accuracy and precision (repeatability and reproducibility by different days and analyst).
Results: The study found that the method demonstrated a linear relationship between the measured values and the concentration of the standard with a correlation coefficient of ≥ 0.980. The accuracy was assessed by spiking known concentrations of endotoxin into samples, the % recovery was within the acceptance criteria of 50-200%. The precision was evaluated by repeatability and intermediate precision studies. The coefficient of variation (CV) of % recovery was less than 25%. It could be used as a standard method for conducting the endotoxin determination in human vaccine and monoclonal antibody products. However, plasma-derived or blood products could not be analyzed due to interference from the samples.
Conclusions: The recombinant factor C method, which has been studied for its accuracy, is suitable and reliable. It can be used as a standard method for analyzing the quality of vaccines and monoclonal antibodies sold in Thailand.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. กระทรวงสาธารณสุข. กฎกระทรวงว่าด้วยการรับรองรุ่นการผลิตยาแผนปัจจุบันที่เป็นยาชีววัตถุ พ.ศ. 2553 [เข้าถึงเมื่อ 23 ก.ย. 2567]. ราชกิจจานุเบกษา เล่ม127, ตอนที่ 66 ก (ลงวันที่ 3 พฤศจิกายน 2553). เข้าถึงได้จาก: https://drug.fda.moph.go.th/ministerial-regulations/bio-product-certification
2. Sandle T. Pharmaceutical microbiology: essentials for quality assurance and quality control: Chapter 11 Endotoxin and pyrogen testing. United Kingdom: Woodhead; 2016. p. 131-145.
3. Beishuizen A, Thijs LG. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res. 2003;9(1):3-24.
4. Atlantic States Marine Fisheries Commission. Review of the interstate fishery management plan: Horseshoe crab (Limulus polyphemas) 2022 Fishing year [Internet]. Arlington: Plan Review Team; 2023 [cited 2024 Jan 14]. Available from: https://asmfc.org/wp-content/uploads/2025/01/HSC_FMP_Review_FY2022.pdf
5. Tindall B, Demircioglu D, Uhlig T. Recombinant bacterial endotoxin testing: a proven solution. BioTechniques 2021;70(5):1-11.
6. Piehler M, Roeder R, Blessing S, Reich J. Comparison of LAL and rFC assays: participation in a proficiency test program between 2014 and 2019. Microorganisms 2020;8(418):1-11.
7. Maloney T, Phelan R, Simmons N. Saving the horseshoe crab: a synthetic alternative to horseshoe crab blood for endotoxin detection. PLoS Biol 2018;16(10):1-10.
8. Gorman R. Atlantic horseshoe crabs and endotoxin testing: perspectives on alternatives, sustainable methods, and the 3Rs (replacement, reduction, and refinement). Front Mar Sci 2020;7:1-11.
9. European Directorate for the Quality of Medicine & HealthCare of the Council of Europe. European Pharmacopoeia: 2.6.32 Test for bacterial endotoxins using recombinant factor C. 11th ed. Strasbourg: Council of Europe; 2022. p. 252-254.
10. United States Pharmacopeia and the National Formulary. <86> Bacteria endotoxins test using recombinant reagents [Internet]. 2022 [cited 2024 Jan 25]. Available from: https://online.uspnf.com/uspnf/document/2_GUID-340F38C0-BC8B-4A80-A8BD-F9BA702EEF7B_10101_en-US?source=Search%20Results&highlight=86
11. Lonza Walkersville, Inc. PyroGene Recombinant Factor C Endotoxin Detection Assay [Internet]. 2012 [cited 2024 Jan 21];1-30 Available from: https://bioscience.lonza.com/lonza_bs/CH/en/download/product/asset/30836
12. Lonza Walkersville, Inc., editor. Endotoxin detection: method revies different approaches to the bacterial endotoxins test. Trends and improvements in endotoxin testing; 2016 Sep 22; Bangkok. Thailand. Bangkok: Thai Can Biotech; 2016.
13. Lonza Walkersville, Inc. Limulus Amebocyte Lysate (LAL) Pyrogent 5000 [Internet]. 2007 [cited 2024 Jan 21];1-28. Available from: https://www.lonzabio.jp/products/endotoxin/pdf/00190233_en.pdf
14. Lonza Walkersville, Inc. Pyrosperse Dispersing Agent [Internet]. 2013 [cited 2024 Jan 21];1-28. Available from: https://bioscience.lonza.com/lonza_bs/CH/en/download/product/asset/27876
15. Lonza Walkersville, Inc. Serum/Plasma testing with PYROGENTTM-5000 and Kinetic-QCLTM assays technical tips [Internet]. 2012 [cited 2024 Sep 23];1-2. Available from: https://www.researchgate.net/profile/Thomas-Winkler-12/post/What_is_the_best_method_to_measure_endotoxin_LPS_in_serum_samples/attachment/5a6060884cde266d58841aa7/AS%3A584074448084992%401516265608321/download/Serum+Plasma+Testing.pdf
16. Tamura H, Reich J, Nagaoka I. Outstanding contributions of LAL technology to pharmaceutical and medical science: Review of methods, progress, challenges, and future perspectives in early detection and management of bacterial infections and invasive fungal diseases. Biomedicines 2021;9(536):1-15.
17. Lilley E, Bruysters M, Das P, Gill S, Isbrucker R, Jonesf D, Holmes A. Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of national control laboratories and national regulatory authorities. Biologicals 2023;84:1-9.
